Initial company report · November 3, 2026

Elevance Health Findings

Anthem, Wellpoint, Carelon and Simply Healthcare Plans (Florida).

This is an initial source collection, not a complete 2020-forward enforcement audit. Inclusion does not imply wrongdoing. Financial enforcement comparisons are pending original-notice and duplicate checks; missing figures do not mean zero actions.

Recent company updates

New developments.

No company-specific daily news entries have been added yet. The initial research report below retains its stated cutoff.

November 20 targeted review added CMS program-wide ACO results. Company and state coverage remains incomplete.

CMS and managed care news archive

Entities and member services

Elevance lists Simply Healthcare Plans as a Florida Medicaid and Medicare managed care company. Carelon includes pharmacy and healthcare services; company-level results must not be attributed to Simply Healthcare alone.

Elevance affiliated-plan listing

Carelon Behavioral Health and CarelonRx are included in this research scope. Historical brand names and ownership at the time of each action require record-specific verification.

Enforcement and legal posture

Historical complaint · allegations

DOJ sued Anthem over diagnosis-data certifications

On March 27, 2020, DOJ announced a civil fraud complaint alleging inaccurate Medicare Advantage risk-adjustment diagnosis submissions and failure to delete unsupported codes. This announcement establishes allegations, not a finding of liability. Current disposition has not been verified for this report. No settlement, fine or paid amount is assigned.

DOJ complaint announcement

CMS notice and repayment leads remain under review. They are excluded from this page's financial comparisons until underlying documents and duplicates are reconciled.

Quarterly financial disclosure

Published October 21, 2026 · Quarter ended September 30, 2026 · Historical backfill added November 3

Elevance reported operating revenue of $50.4 billion, GAAP diluted earnings of $6.27 per share and adjusted diluted earnings of $6.99 per share. Carelon operating revenue was $19.3 billion. The company raised full-year guidance to at least $22.00 GAAP and $29.00 adjusted earnings per share. Adjusted measures require the release's GAAP reconciliation; guidance is forward-looking.

SEC-filed earnings release

Operating revenue and earnings are not enforcement amounts or measures of care quality. Carelon segment revenue is not additive to consolidated revenue because intercompany activity must be considered.

Executive leadership, pay and workforce

In its February 26, 2026 announcement, Elevance assigned expanded Carelon oversight to CFO Mark Kaye and consolidated Health Benefits leadership to Felicia Norwood. These are company-announced responsibilities, not a complete current executive directory.

Dated leadership announcement

Executive pay, benefits and separation terms have not yet been reconciled from the 2026 proxy. No compensation total or turnover cost is presented. This report does not establish layoffs followed by replacement hiring; that requires matching dated roles, locations and postings.

Next research steps

Contracts and care-access findings are not yet complete. Existing company comparisons retain their dated scope and do not rank Elevance as having no actions.